‘Sticky’ particles promise more precise drug delivery for brain cancer
A Yale research team has found that by tinkering with the surface properties of drug-loaded nanoparticles, they can potentially direct these particles to specific cells in the brain. By making nanoparticles bioadhesive, or “sticky,” the researchers have answered a long-standing question: Once you get the particles to the brain, how do you get them to interact with the cancer cells there? Their findings are published May 19 in Nature Communications.
Unmet Clinical Needs
On October 27, the Yale Center for Biomedical and Interventional Technology (CBIT), a YCCI emerging core, hosted Clinician Pitch Night. More than ninety students from Yale College, the School of Management, the School of Medicine, and the Graduate School of Arts and Sciences gathered to listen to pitches from clinicians seeking creative, efficient, and cost-effective solutions to challenging problems that arise in caring for patients.
CaSB@Yale launches with $9.5M federal grant to battle deadliest cancers
Yale University researchers across a spectrum of disciplines are coming together to fight some of the deadliest forms of cancer with a novel approach that has gained support from the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
Yale Start-Up Wins $250,000 grant from USAID’s Saving Lives at Birth Partnership
PremieBreathe, a start-up created by Yale students and faculty, has been awarded a $250,0000 grant from the USAID’s Saving Lives at Birth partnership for its breathing aid for premature infants.Source: Yale School of Engineering & Applied Science
From Nanotechnology, A Better Prognostic Tool For Brain Cancer
A new nano-fabricated platform for observing brain cancer cells provides a much more detailed look at how the cells migrate and a more accurate post-surgery prognosis for brain cancer (glioblastoma) patients.Source: Yale School of Engineering and Applied Science
Bioengineered blood vessel is safe for dialysis patients, study finds
A Yale scientist collaborated with researchers at Duke University and surgeons in Poland and the United States to create bioengineered blood vessels for kidney-disease patients on dialysis. The man-made vessels appeared to be both safe and more durable than commonly used synthetic versions, said the investigators.
New paradigm in medicine: population health — a Q&A with Dr. Brita Roy
Dr. Brita Roy started her career in biomedical engineering, focusing on problems such as how to develop better artificial hearts or drugs. But with a desire to work more directly with patients, she switched to medicine where she started to see that the advanced medical technologies she’d studied as an engineer would have little impact if patients did not learn how to manage their own health and well-being.